Literature DB >> 12795716

Evidence for impaired axonal regeneration in PMP22 duplication: studies in nerve xenografts.

Zarife Sahenk1, Carmen Serrano-Munuera, Lei Chen, Inga Kakabadze, Haikady N Najagara.   

Abstract

Whether axonal regeneration in Charcot-Marie-Tooth (CMT) neuropathies is impaired has not been addressed in detail. Our studies in nude mice harboring xenografts from patients with different primary Schwann cell (SC) genetic defects suggested an intimate association between the onset of myelination and impairment in the growth capacity of nude mice axons engulfed by the mutant SCs. To assess the effects of peripheral myelin protein 22 (PMP22) gene duplication on the regeneration process, we conducted morphometric studies to generate temporal growth profiles of myelinated axons within the xenografts obtained from CMT1A patients and from healthy controls. Axon size distribution histograms in controls at different time intervals revealed that size differentiation of myelinated fibers within the grafts is established as early as 2 weeks, and that the temporal pattern of myelination of different sized axons has striking similarities to myelination during development. In PMP22 duplication grafts, the onset of myelination is delayed and the regeneration capacity of all fiber sizes is impaired. This defect, however, is most pronounced for the large diameter axons. In addition, significant large fiber loss occurred after 12 weeks with a concomitant new cycle of regeneration of small size axons. These studies show that the PMP22 duplication in SCs have profound effects on the regeneration process, which might be a contributing factor to preferential distal axonal loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12795716     DOI: 10.1046/j.1529-8027.2003.03017.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  5 in total

Review 1.  Mechanisms and Treatments in Demyelinating CMT.

Authors:  Vera Fridman; Mario A Saporta
Journal:  Neurotherapeutics       Date:  2021-11-08       Impact factor: 6.088

Review 2.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

3.  Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32.

Authors:  Charles K Abrams; Mona Freidin; Feliksas Bukauskas; Kostantin Dobrenis; Thaddeus A Bargiello; Vytas K Verselis; Michael V L Bennett; Lei Chen; Zarife Sahenk
Journal:  J Neurosci       Date:  2003-11-19       Impact factor: 6.167

4.  AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.

Authors:  Zarife Sahenk; Gloria Galloway; Kelly Reed Clark; Vinod Malik; Louise R Rodino-Klapac; Brian K Kaspar; Lei Chen; Cilwyn Braganza; Chrystal Montgomery; Jerry R Mendell
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

5.  AAV1.NT-3 gene therapy for X-linked Charcot-Marie-Tooth neuropathy type 1.

Authors:  Burcak Ozes; Morgan Myers; Kyle Moss; Jennifer Mckinney; Alicia Ridgley; Lei Chen; Shasha Bai; Charles K Abrams; Mona M Freidin; Jerry R Mendell; Zarife Sahenk
Journal:  Gene Ther       Date:  2021-02-04       Impact factor: 5.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.